Institutional Ownership
Day One Biopharmaceuticals I
CUSIP 23954D109COMDAWNGBXQ1 2026
Institutional Holders
199
13F filers
Shares Held
80.76M
Aggregate institutional
Institutional Value
$1.61B
Q1 2026
Net New Holders
+18
74 new · 56 closed
Institutional Ownership Trend
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradePosition Activity
Q1 2026
New positions74
Increased61
Decreased47
Sold out56
Institutional Holders
199 funds hold this security · Q1 2026
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Blackrock, Inc. | 7.04M | $151.03M | −1.79M | Reduced |
| 2 | Fil Ltd | 4.13M | $88.59M | +4.13M | New |
| 3 | Kryger Capital LLC | 3.90M | $83.54M | +3.90M | First Filing |
| 4 | Deerfield Management Company, L.P. | 3.72M | $79.82M | 0 | Held |
| 5 | Jpmorgan Chase & Co | 3.13M | $67.15M | +3.09M | Added |
| 6 | State Street Corp | 2.87M | $61.53M | −1.42M | Reduced |
| 7 | Balyasny Asset Management L.P. | 2.63M | $56.29M | +1.14M | Added |
| 8 | Aqr Arbitrage LLC | 2.46M | $52.79M | +2.46M | New |
| 9 | Ubs Group AG | 2.31M | $49.42M | +2.13M | Added |
| 10 | Geode Capital Management, LLC | 1.95M | $41.92M | +76.9K | Added |
189 more institutional holders on Premium
See every fund holding Day One Biopharmaceuticals I, with full quarter-over-quarter share changes.
Unlock all holders